175 related articles for article (PubMed ID: 20308603)
1. Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation.
Royer RH; Koshiol J; Giambarresi TR; Vasquez LG; Pfeiffer RM; McMaster ML
Blood; 2010 Jun; 115(22):4464-71. PubMed ID: 20308603
[TBL] [Abstract][Full Text] [Related]
2. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.
Kristinsson SY; Koshiol J; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
J Natl Cancer Inst; 2010 Apr; 102(8):557-67. PubMed ID: 20181958
[TBL] [Abstract][Full Text] [Related]
3. Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Vajdic CM; Landgren O; McMaster ML; Slager SL; Brooks-Wilson A; Smith A; Staines A; Dogan A; Ansell SM; Sampson JN; Morton LM; Linet MS
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):87-97. PubMed ID: 25174029
[TBL] [Abstract][Full Text] [Related]
4. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
[TBL] [Abstract][Full Text] [Related]
5. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.
Brandefors L; Kimby E; Lundqvist K; Melin B; Lindh J
Acta Oncol; 2016; 55(1):91-8. PubMed ID: 26559865
[TBL] [Abstract][Full Text] [Related]
6. Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Hultcrantz M; Pfeiffer RM; Björkholm M; Goldin LR; Turesson I; Schulman S; Landgren O; Kristinsson SY
J Thromb Haemost; 2014 Nov; 12(11):1816-21. PubMed ID: 25196979
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia.
Roccaro AM; Sacco A; Shi J; Chiarini M; Perilla-Glen A; Manier S; Glavey S; Aljawai Y; Mishima Y; Kawano Y; Moschetta M; Correll M; Improgo MR; Brown JR; Imberti L; Rossi G; Castillo JJ; Treon SP; Freedman ML; Van Allen EM; Hide W; Hiller E; Rainville I; Ghobrial IM
Blood; 2016 May; 127(21):2598-606. PubMed ID: 26903547
[TBL] [Abstract][Full Text] [Related]
8. Familial Waldenstrom's macroglobulinemia.
McMaster ML
Semin Oncol; 2003 Apr; 30(2):146-52. PubMed ID: 12720125
[TBL] [Abstract][Full Text] [Related]
9. Familial disease predisposition impacts treatment outcome in patients with Waldenström macroglobulinemia.
Treon SP; Tripsas C; Hanzis C; Ioakimidis L; Patterson CJ; Manning RJ; Sheehy P; Turnbull B; Hunter ZR
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):433-7. PubMed ID: 23084402
[TBL] [Abstract][Full Text] [Related]
10. Chronic immune stimulation and subsequent Waldenström macroglobulinemia.
Koshiol J; Gridley G; Engels EA; McMaster ML; Landgren O
Arch Intern Med; 2008 Sep; 168(17):1903-9. PubMed ID: 18809818
[TBL] [Abstract][Full Text] [Related]
11. Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.
Kristinsson SY; Goldin LR; Turesson I; Björkholm M; Landgren O
Acta Haematol; 2012; 127(3):173-7. PubMed ID: 22310551
[TBL] [Abstract][Full Text] [Related]
12. Familial Waldenström Macroglobulinemia: Families Informing Populations.
McMaster ML
Hematol Oncol Clin North Am; 2018 Oct; 32(5):787-809. PubMed ID: 30190018
[TBL] [Abstract][Full Text] [Related]
13. Screening and identification of a novel FHL2 mutation by whole exome sequencing in twins with familial Waldenström macroglobulinemia.
Wan Y; Cheng Y; Liu Y; Shen L; Hou J
Cancer; 2021 Jun; 127(12):2039-2048. PubMed ID: 33764527
[TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families.
McMaster ML; Csako G; Giambarresi TR; Vasquez L; Berg M; Saddlemire S; Hulley B; Tucker MA
Clin Cancer Res; 2007 Sep; 13(17):5063-9. PubMed ID: 17785558
[TBL] [Abstract][Full Text] [Related]
15. Associated malignancies in patients with Waldenström's macroglobulinemia and their kin.
Hanzis C; Ojha RP; Hunter Z; Manning R; Lewicki M; Brodsky P; Ioakimidis L; Tripsas C; Patterson CJ; Sheehy P; Treon SP
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):88-92. PubMed ID: 21454200
[TBL] [Abstract][Full Text] [Related]
16. Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study.
Jeong S; Kong SG; Kim DJ; Lee S; Lee HS
BMC Cancer; 2020 Jul; 20(1):623. PubMed ID: 32620091
[TBL] [Abstract][Full Text] [Related]
17. Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary study.
Ojha RP; Hanzis CA; Hunter ZR; Greenland S; Offutt-Powell TN; Manning RJ; Lewicki M; Brodsky PS; Ioakimidis L; Tripsas CK; Patterson CJ; Sheehy P; Singh KP; Treon SP
Cancer Epidemiol; 2012 Jun; 36(3):294-7. PubMed ID: 22099500
[TBL] [Abstract][Full Text] [Related]
18. Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Hunter ZR; Kanan S; Meid K; Treon SP
Cancer; 2015 Jul; 121(13):2230-6. PubMed ID: 25757851
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired infections associated with increased risk of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia.
McShane CM; Murray LJ; Engels EA; Anderson LA
Br J Haematol; 2014 Mar; 164(5):653-8. PubMed ID: 24528127
[TBL] [Abstract][Full Text] [Related]
20. Associated cancers in Waldenström macroglobulinemia: clues for common genetic predisposition.
Morra E; Varettoni M; Tedeschi A; Arcaini L; Ricci F; Pascutto C; Rattotti S; Vismara E; Paris L; Cazzola M
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):700-3. PubMed ID: 24070824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
